Example: Heart Attack

Search clinical trials for: Fasudil

Total 12 results

NCT01935518

Unknown status

A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Conditions: Amyotrophic Lateral Sclerosis
NCT03753269

Not yet recruiting

Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction

Conditions: ST Segment Elevation Myocardial Infarction
NCT03792490

Recruiting

Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

Conditions: Amyotrophic Lateral Sclerosis
NCT00498615

Completed

A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon

Conditions: Raynaud; Scleroderma
NCT04793659

Recruiting

Fasudil fOr redUcing elopemeNt and Spatial Disorientation

Conditions: Dementia
NCT04734379

Recruiting

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1

Conditions: Progressive Supranuclear Palsy; Corticobasal Syndrome
NCT00670202

Terminated

Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis

Conditions: Carotid Stenosis
NCT04191954

Recruiting

Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)

Conditions: Retinopathy of Prematurity
NCT03391219

Unknown status

Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients

Conditions: Retinal Vein Occlusion
NCT00120718

Completed

The Effect of Fasudil on Vascular Function in Humans

Conditions: Atherosclerosis; Hypercholesterolemia
NCT01823081

Completed

Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT03404843

Completed

Red Blood Cell ATP Release and Vascular Function in Humans

Conditions: Cardiovascular Diseases